How Will the In-Vitro Toxicology Testing Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the in-vitro toxicology testing market grown in recent years?
The scale of the in-vitro toxicology testing market has expanded dramatically in the recent past. Its value is expected to increase from $11.53 billion in 2024 to a staggering $12.77 billion in 2025, with a compound annual growth rate (CAGR) of 10.7%. Various factors have contributed to this robust growth in the historical period, including regulatory obligations, ethical issues and animal welfare considerations, cost-effectiveness, the worldwide expansion of the pharmaceutical sector, the requirements of drug discovery and development, and heightened public awareness about environmental toxins.
How is the in-vitro toxicology testing market size expected to evolve during the forecast period?
The market size for in-vitro toxicology testing is predicted to experience a significant surge in the coming years, expanding to a size of $19.18 billion in 2029 with a compound annual growth rate (CAGR) of 10.7%. This growth during the projected period can be accredited to several factors such as the emphasis on personalized medicine, the need for predictive toxicology models, the broadening of environmental testing, challenges in the development of oncology drugs, the focus on screening endocrine disruptors, and the shift towards multi-organ chips. Key trends anticipated during this forecast period encompass advancements in 3D cell culture technologies, the integration of high-throughput screening, concentration on organ-on-a-chip technologies, their application in chemical safety assessment, the utilization of human-derived cell lines, the infusion of omics technologies, and instituting educational initiatives and training programs.
Get your in-vitro toxicology testing market report here!
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
Which key drivers are propelling the in-vitro toxicology testing market’s growth?
The surge in healthcare spending is forecasted to drive the in-vitro toxicology testing market in the future. Health expenses, encompassing money expended by individuals and the government on hospitals, home health services, prescription medicines, nursing facilities, and personal health care, are on the rise globally on account of increasing disease prevalence that requires in-vitro toxicology testing. In September 2024, the Centers for Medicare & Medicaid Services, a federal agency in the US, revealed in their report that from 2023 to 2032, the average growth rate of national health expenditure (NHE) is predicted to hit 5.6%, overriding the average GDP growth rate of 4.3%. Consequently, health spending’s portion of GDP is anticipated to escalate from 17.3% in 2022 to 19.7% in 2032. This rising healthcare expenditure is thus fueling the growth of the in-vitro toxicology testing market.
What are the market segments in the in-vitro toxicology testing industry?
The in-vitro toxicology testing market covered in this report is segmented –
1) By Product And Service: Consumables, Assays, Equipment, Software, Services
2) By Method: Cellular Assays, Biochemical Assays, In Silico Models, Ex Vivo Models
3) By Technology: Cell Culture Technologies, High-throughput Technologies, Toxicogenomics
4) By Applications: Neurotoxicity, Dermal toxicity, Cytotoxicity, Other Applications
5) By Industry: Pharmaceuticals And Biopharmaceuticals, Cosmetic And Household Products, Food, Chemicals
Subsegments:
1) By Consumables: Reagents, Cell Culture Media, Plates And Vials
2) By Assays: Cell-Based Assays, Biochemical Assays, Genetic Toxicity Assays
3) By Equipment: Automated Systems, Microscopes, Plate Readers
4) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Toxicology Modeling Software
5) By Services: Testing Services, Consultation Services, Regulatory Compliance Services
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7987&type=smp
Which leading companies are shaping the growth of the in-vitro toxicology testing market?
Major companies operating in the in-vitro toxicology testing market are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation
What key trends are currently impacting the in-vitro toxicology testing market’s development?
In the in-vitro toxicology market, there is a growing trend for pioneering cell therapy development. To consolidate their position, main players in the in-vitro toxicology testing market are investing in novel financing solutions. As an example, Waypoint Bio, a biotechnology firm based in the US, unveiled a seed funding scheme for innovative cell therapies for solid tumors, backed with $14.5 million in June 2024. Utilizing in vivo spatial pooled screening technology, the platform distinctly combines spatial biology with pooled screening to allow concurrent analysis of a variety of cell therapy possibility reactions with the microenvironment of solid tumors. By analyzing hundreds of phenotypes at a single-cell level, the system provides insight into not only the effectiveness of therapies, but also the reasons behind their successes or failures, based on their interactions with the tumor environment.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7987
Which geographic areas are influencing the growth of the in-vitro toxicology testing market?
North America was the largest region in the in- vitro toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in the in-vitro toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Anesthesia Equipment Global Market Report 2024
Veterinary Medical Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-medical-equipment-global-market-report
Veterinary Laboratory Testing Services Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
